首页 > 最新文献

International Journal of Health Planning and Management最新文献

英文 中文
Waiting for Specialists: A Multi-Priority and Multi-Speciality Analysis 等待专家:多优先和多专业分析。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-07-12 DOI: 10.1002/hpm.70007
Pedro G. Rodrigues, Maria João Bárrios, Marta S. G. Mendes

Managing waiting times for specialist consultations is a critical challenge for healthcare systems worldwide. This study examines how hospitals manage outpatient specialist consultations through multi-priority systems, analysing nearly a million consultations across 29 medical specialities at a major Portuguese hospital (2010–2019). Using fixed-effects models with Driscoll-Kraay standard errors, we investigate how operational factors affect waiting times for first consultations across three priority levels. Each additional day spent in triage adds 0.52 days to urgent consultation waits (p < 0.10) but 1.41 days for routine cases (p < 0.01), demonstrating how delays cascade through the system. Staffing changes primarily benefit routine consultations, reducing waiting times by 1.88 days per additional specialist (p < 0.05). Our analysis reveals sophisticated cross-priority effects: backlogs in higher-priority cases significantly increase waiting times for lower-priority consultations, with each additional high-priority case increasing normal-priority waits by 0.15 days (p < 0.001), showing how hospitals actively protect urgent access while systematically managing delays for routine appointments. Provider-initiated cancellations disproportionately affect lower-priority cases (0.03 days, p < 0.01), whereas urgent consultations show resilience to scheduling disruptions. A 2017 policy reform reducing maximum waiting times triggered speciality-specific adaptations. Despite increased waiting times across all priority levels (p < 0.05), cardiac units implemented operational adjustments: enhanced triage efficiency (−30.88 days, p < 0.001), improved backlog management (−0.25 days, p < 0.001), and optimised capacity utilization (−0.18 days, p = 0.056). These findings show how hospitals balance clinical prioritisation with system efficiency, as speciality-specific constraints shape access outcomes. We highlight the need for targeted resource allocation and sophisticated triage systems that adapt to changing pressures while maintaining clinical priorities.

管理专家咨询的等待时间是全球卫生保健系统面临的一项重大挑战。本研究考察了医院如何通过多优先系统管理门诊专家咨询,分析了葡萄牙一家主要医院(2010-2019年)29个医学专业的近100万次咨询。使用具有Driscoll-Kraay标准误差的固定效应模型,我们调查了操作因素如何影响三个优先级的首次咨询等待时间。在分诊中每多花一天时间,紧急会诊等待时间就会增加0.52天
{"title":"Waiting for Specialists: A Multi-Priority and Multi-Speciality Analysis","authors":"Pedro G. Rodrigues,&nbsp;Maria João Bárrios,&nbsp;Marta S. G. Mendes","doi":"10.1002/hpm.70007","DOIUrl":"10.1002/hpm.70007","url":null,"abstract":"<div>\u0000 \u0000 <p>Managing waiting times for specialist consultations is a critical challenge for healthcare systems worldwide. This study examines how hospitals manage outpatient specialist consultations through multi-priority systems, analysing nearly a million consultations across 29 medical specialities at a major Portuguese hospital (2010–2019). Using fixed-effects models with Driscoll-Kraay standard errors, we investigate how operational factors affect waiting times for first consultations across three priority levels. Each additional day spent in triage adds 0.52 days to urgent consultation waits (<i>p</i> &lt; 0.10) but 1.41 days for routine cases (<i>p</i> &lt; 0.01), demonstrating how delays cascade through the system. Staffing changes primarily benefit routine consultations, reducing waiting times by 1.88 days per additional specialist (<i>p</i> &lt; 0.05). Our analysis reveals sophisticated cross-priority effects: backlogs in higher-priority cases significantly increase waiting times for lower-priority consultations, with each additional high-priority case increasing normal-priority waits by 0.15 days (<i>p</i> &lt; 0.001), showing how hospitals actively protect urgent access while systematically managing delays for routine appointments. Provider-initiated cancellations disproportionately affect lower-priority cases (0.03 days, <i>p</i> &lt; 0.01), whereas urgent consultations show resilience to scheduling disruptions. A 2017 policy reform reducing maximum waiting times triggered speciality-specific adaptations. Despite increased waiting times across all priority levels (<i>p</i> &lt; 0.05), cardiac units implemented operational adjustments: enhanced triage efficiency (−30.88 days, <i>p</i> &lt; 0.001), improved backlog management (−0.25 days, <i>p</i> &lt; 0.001), and optimised capacity utilization (−0.18 days, <i>p</i> = 0.056). These findings show how hospitals balance clinical prioritisation with system efficiency, as speciality-specific constraints shape access outcomes. We highlight the need for targeted resource allocation and sophisticated triage systems that adapt to changing pressures while maintaining clinical priorities.</p>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 6","pages":"1248-1278"},"PeriodicalIF":1.8,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144620850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inequality in Health Insurance Coverage in a Pluralistic Health Insurance System: Evidence From India 多元医疗保险制度中医疗保险覆盖面的不平等:来自印度的证据。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-07-11 DOI: 10.1002/hpm.70008
Pragyan Monalisa Sahoo, Himanshu Sekhar Rout

Background

Persistent inequality in financial protection mechanisms in healthcare continues to be a major challenge within India's pluralistic health insurance system, disproportionately disadvantaging marginalised groups.

Methods

Our study uses NFHS 4 and 5 household data to investigate inequality in health insurance coverage prevalence and transition across socioeconomic and demographic strata. It categorises health insurance coverage based on the number and type of coverage, considering factors such as the provider, pooling mechanism, and target population. We employ descriptive statistics and the concentration index to assess the prevalence of health insurance coverage. To delve deeper into the factors influencing enrolment in different types of coverage, we created 24 mutually exclusive groups at the intersection of sex-income-marriage-caste. These categories, along with other explanatory variables, are analysed for their influence on the enrolment of coverage using multinomial logistic regression models.

Results

Although the proportion of health insurance coverage increased from NFHS 4 to NFHS 5, 59.01% of the sample population still lacked coverage, indicating insufficient progress. Both surveys reveal significant disparities in coverage based on state-level, social, economic, and demographic factors. While the role of social and demographic determinants remains relatively modest, the distributional gradient of insurance prevalence across economic strata and state categories was high. India's pluralistic health insurance system has resulted in the population being covered under different coverage mechanisms. However, among these various types of coverage, the majority of sample households were only single, predominantly under SHI.

Conclusions

The study investigated disparities in health insurance coverage across various social, economic, and demographic segments in India, revealing that inequalities are influenced by a combination of state-level, socioeconomic, and demographic factors. These findings call for a unified and inclusive health financing framework that can address systemic fragmentation. Moving towards a ‘One Nation, One Insurance’ model offers a transformative pathway to ensure equitable, efficient, and universal health coverage for all Indians. Addressing these determinants presents potential policy tools for improving coverage imbalances, thereby offering opportunities for targeted interventions to mitigate disparities.

背景:医疗保健金融保护机制的持续不平等仍然是印度多元化医疗保险体系中的一个主要挑战,对边缘化群体造成不成比例的不利影响。方法:本研究使用NFHS 4和5家庭数据,调查不同社会经济和人口阶层的健康保险覆盖普及率和过渡的不平等。它根据保险的数量和类型对医疗保险进行分类,同时考虑到提供者、统筹机制和目标人群等因素。我们采用描述性统计和浓度指数来评估健康保险覆盖的普及程度。为了更深入地研究影响不同类型覆盖的入学率的因素,我们在性别、收入、婚姻和种姓的交叉点创建了24个相互排斥的群体。使用多项逻辑回归模型分析了这些类别以及其他解释变量对覆盖率登记的影响。结果:虽然健康保险覆盖比例从NFHS 4提高到NFHS 5,但仍有59.01%的样本人口缺乏健康保险覆盖,进展不足。两项调查都揭示了基于州一级、社会、经济和人口因素的覆盖率存在显著差异。虽然社会和人口决定因素的作用仍然相对温和,但保险普及率在经济阶层和国家类别之间的分布梯度很高。印度多元化的医疗保险制度导致人口在不同的保险机制下得到覆盖。然而,在这些不同类型的覆盖中,大多数样本家庭只是单身,主要是在SHI下。结论:该研究调查了印度不同社会、经济和人口阶层在医疗保险覆盖方面的差异,揭示了不平等受到邦一级、社会经济和人口因素的综合影响。这些发现呼吁建立一个统一和包容性的卫生筹资框架,以解决系统性碎片化问题。向“一国一险”模式迈进提供了一条变革性的途径,以确保所有印度人享有公平、高效和普遍的医疗保险。解决这些决定因素为改善覆盖不平衡提供了潜在的政策工具,从而为有针对性的干预措施提供了机会,以减轻差距。
{"title":"Inequality in Health Insurance Coverage in a Pluralistic Health Insurance System: Evidence From India","authors":"Pragyan Monalisa Sahoo,&nbsp;Himanshu Sekhar Rout","doi":"10.1002/hpm.70008","DOIUrl":"10.1002/hpm.70008","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Persistent inequality in financial protection mechanisms in healthcare continues to be a major challenge within India's pluralistic health insurance system, disproportionately disadvantaging marginalised groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Our study uses NFHS 4 and 5 household data to investigate inequality in health insurance coverage prevalence and transition across socioeconomic and demographic strata. It categorises health insurance coverage based on the number and type of coverage, considering factors such as the provider, pooling mechanism, and target population. We employ descriptive statistics and the concentration index to assess the prevalence of health insurance coverage. To delve deeper into the factors influencing enrolment in different types of coverage, we created 24 mutually exclusive groups at the intersection of sex-income-marriage-caste. These categories, along with other explanatory variables, are analysed for their influence on the enrolment of coverage using multinomial logistic regression models.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Although the proportion of health insurance coverage increased from NFHS 4 to NFHS 5, 59.01% of the sample population still lacked coverage, indicating insufficient progress. Both surveys reveal significant disparities in coverage based on state-level, social, economic, and demographic factors. While the role of social and demographic determinants remains relatively modest, the distributional gradient of insurance prevalence across economic strata and state categories was high. India's pluralistic health insurance system has resulted in the population being covered under different coverage mechanisms. However, among these various types of coverage, the majority of sample households were only single, predominantly under SHI.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The study investigated disparities in health insurance coverage across various social, economic, and demographic segments in India, revealing that inequalities are influenced by a combination of state-level, socioeconomic, and demographic factors. These findings call for a unified and inclusive health financing framework that can address systemic fragmentation. Moving towards a ‘One Nation, One Insurance’ model offers a transformative pathway to ensure equitable, efficient, and universal health coverage for all Indians. Addressing these determinants presents potential policy tools for improving coverage imbalances, thereby offering opportunities for targeted interventions to mitigate disparities.</p>\u0000 </section>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 6","pages":"1232-1247"},"PeriodicalIF":1.8,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144609896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What a State: Why the U.S. is Still Bad for Your Health (Policy) 什么是国家:为什么美国仍然对你的健康有害(政策)。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-07-09 DOI: 10.1002/hpm.70009
Calum Paton

The second Trump administration's centrepiece legislation, the modestly-named Big Beautiful Bill, passed by the House of Representatives and going through the Senate at time of writing, offers an opportunity to reflect upon how the U.S. state affects health policy and the prospects for equitable access to affordable healthcare. Is the U.S. still an outlier (by comparison with Europe and much of the world), in that its many of its citizens are either uncovered, poorly covered or tenuously and only temporarily covered by health insurance? The answer is yes. And the chipping away at Obamacare and Medicaid by Trump 2.0 (learning from his failure to repeal Obamacare in 2017) as part of the Big Beautiful Bill, shows us that it is easier for the Right to dismantle progressive social legislation than it is for the Liberal-Left to assemble it. To understand why, and to revisit why the U.S. polity struggles to enact progressive healthcare reform, we have to understand the effect of the U.S. state (i.e. political structure) upon public policy. This article revisits the nature of that state, to depict the underlying causes of ‘American exceptionalism’ which are partly ideological but also more significantly institutional than often realised.

特朗普第二届政府的核心立法——名为《大美丽法案》(Big Beautiful Bill),由众议院通过,在撰写本文时正在参议院审议。该法案提供了一个机会,让人们反思美国政府如何影响医疗政策,以及公平获得可负担医疗服务的前景。与欧洲和世界大部分地区相比,美国的许多公民要么没有医保,要么医保覆盖很差,要么医保覆盖很弱,而且只是暂时的,美国是否仍然是一个异类?答案是肯定的。特朗普2.0(从他2017年废除奥巴马医改的失败中吸取教训)将奥巴马医改和医疗补助作为“美丽大法案”(Big Beautiful Bill)的一部分,这向我们表明,对右翼来说,废除进步的社会立法比自由左翼要容易得多。要理解为什么,并重新审视为什么美国政府努力制定渐进式医疗改革,我们必须了解美国国家(即政治结构)对公共政策的影响。本文重新审视了这种状态的本质,描绘了“美国例外论”的根本原因,这种原因部分是意识形态的,但也比人们通常意识到的更重要。
{"title":"What a State: Why the U.S. is Still Bad for Your Health (Policy)","authors":"Calum Paton","doi":"10.1002/hpm.70009","DOIUrl":"10.1002/hpm.70009","url":null,"abstract":"<p>The second Trump administration's centrepiece legislation, the modestly-named Big Beautiful Bill, passed by the House of Representatives and going through the Senate at time of writing, offers an opportunity to reflect upon how the U.S. state affects health policy and the prospects for equitable access to affordable healthcare. Is the U.S. still an outlier (by comparison with Europe and much of the world), in that its many of its citizens are either uncovered, poorly covered or tenuously and only temporarily covered by health insurance? The answer is yes. And the chipping away at Obamacare and Medicaid by Trump 2.0 (learning from his failure to repeal Obamacare in 2017) as part of the Big Beautiful Bill, shows us that it is easier for the Right to dismantle progressive social legislation than it is for the Liberal-Left to assemble it. To understand why, and to revisit why the U.S. polity struggles to enact progressive healthcare reform, we have to understand the effect of the U.S. state (i.e. political structure) upon public policy. This article revisits the nature of that state, to depict the underlying causes of ‘American exceptionalism’ which are partly ideological but also more significantly institutional than often realised.</p>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 6","pages":"1326-1334"},"PeriodicalIF":1.8,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hpm.70009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
‘What is Your Job?’: A Qualitative Analysis of the Deployment, Utilisation, and Contribution of Support Workers in Diagnostic Imaging Services in England “你的工作是什么?”:对英国诊断成像服务中支持工作者的部署、利用和贡献的定性分析。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-07-05 DOI: 10.1002/hpm.70005
Sarah Etty, Beverly Snaith, Robert Appleyard, Julie Nightingale

Support workers (SWs) form the largest section of the NHS workforce, and the ongoing NHS workforce crisis underscores the need for their efficient utilisation. This study explored the deployment of imaging SWs within NHS radiology departments in England, forming part of a larger multiphase research project funded by the National Institute for Health Research (NIHR). It involved multi-centre case studies across nine radiology departments, employing a thematic analysis of focus groups and interviews with a range of radiology staff, including SWs themselves (n = 113). Results showed that recruitment of SWs was generally not challenging, however, retention was variable potentially due to limited opportunities for career progression and a lack of role understanding. Deployment strategies varied significantly across sites, which sometimes influenced SW effectiveness and were often selected for service need rather than SW development. Role scope was often unclear and training inconsistent which may exacerbate poor role understanding, and the lack of clear career pathways outside of professional registration conflicted with SWs' strong desire for progression. SWs are highly valued, crucial to operational efficiency and excellent patient care. Efficient deployment of SWs within NHS radiology services is crucial for alleviating workforce shortages and improving service delivery, however, this is impeded by the variability in role definition and deployment practices evidenced in this study. Standardising role titles, responsibilities, and training, and creating clear progression pathways could help to fully harness the capabilities of SWs in healthcare settings. National frameworks offer recommendations for standardisation, but this study suggests implementation remains inconsistent or delayed.

支持工作者(SWs)构成了NHS劳动力的最大部分,正在进行的NHS劳动力危机强调了他们有效利用的必要性。本研究探讨了成像SWs在英国NHS放射科的部署,这是由国家卫生研究所(NIHR)资助的一个更大的多阶段研究项目的一部分。它涉及九个放射科的多中心案例研究,采用焦点小组的专题分析和对一系列放射科工作人员的访谈,包括SWs本身(n = 113)。结果表明,招聘SWs通常没有挑战性,然而,由于职业发展机会有限和缺乏角色理解,挽留率可能会有所变化。部署策略在不同的站点之间差异很大,这有时会影响软件的有效性,并且通常是根据服务需求而不是软件开发而选择的。角色范围往往不明确,培训不一致,这可能会加剧对角色的不理解,并且在专业注册之外缺乏明确的职业道路,这与SWs强烈的晋升愿望相冲突。SWs的价值很高,对运营效率和出色的患者护理至关重要。在NHS放射服务中有效部署SWs对于缓解劳动力短缺和改善服务提供至关重要,然而,这受到本研究中所证明的角色定义和部署实践的变化的阻碍。标准化角色名称、职责和培训,并创建明确的晋升途径,有助于充分利用医疗保健环境中社会服务人员的能力。国家框架为标准化提供了建议,但这项研究表明,实施仍然不一致或延迟。
{"title":"‘What is Your Job?’: A Qualitative Analysis of the Deployment, Utilisation, and Contribution of Support Workers in Diagnostic Imaging Services in England","authors":"Sarah Etty,&nbsp;Beverly Snaith,&nbsp;Robert Appleyard,&nbsp;Julie Nightingale","doi":"10.1002/hpm.70005","DOIUrl":"10.1002/hpm.70005","url":null,"abstract":"<p>Support workers (SWs) form the largest section of the NHS workforce, and the ongoing NHS workforce crisis underscores the need for their efficient utilisation. This study explored the deployment of imaging SWs within NHS radiology departments in England, forming part of a larger multiphase research project funded by the National Institute for Health Research (NIHR). It involved multi-centre case studies across nine radiology departments, employing a thematic analysis of focus groups and interviews with a range of radiology staff, including SWs themselves (<i>n</i> = 113). Results showed that recruitment of SWs was generally not challenging, however, retention was variable potentially due to limited opportunities for career progression and a lack of role understanding. Deployment strategies varied significantly across sites, which sometimes influenced SW effectiveness and were often selected for service need rather than SW development. Role scope was often unclear and training inconsistent which may exacerbate poor role understanding, and the lack of clear career pathways outside of professional registration conflicted with SWs' strong desire for progression. SWs are highly valued, crucial to operational efficiency and excellent patient care. Efficient deployment of SWs within NHS radiology services is crucial for alleviating workforce shortages and improving service delivery, however, this is impeded by the variability in role definition and deployment practices evidenced in this study. Standardising role titles, responsibilities, and training, and creating clear progression pathways could help to fully harness the capabilities of SWs in healthcare settings. National frameworks offer recommendations for standardisation, but this study suggests implementation remains inconsistent or delayed.</p>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 6","pages":"1220-1231"},"PeriodicalIF":1.8,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hpm.70005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144568000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Out-of-Pocket Expenditure and its Determinants Amongst the Patients Undergoing Advanced Radiological Procedures in the Public Healthcare Facilities of Tamil Nadu, South India 南印度泰米尔纳德邦公共医疗机构接受高级放射治疗的患者自费支出及其决定因素
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-06-29 DOI: 10.1002/hpm.70006
Dhanajayan Govindan, Suthanthira Kannan, Deivasigamani Kuberan, Arivarasan Barathi, Venmathi Elangovan, Afrith John Poul, Muneera Parveen, Marie Gilbert Majella, Yuvaraj Krishnamoorthy

Background

Advanced radiological procedures, such as CT, MRI, and PET scans, are crucial for accurate diagnostics and treatment planning but often result in substantial out-of-pocket expenditures (OOPE) for patients, especially in developing countries like India. Despite progressive health policies in Tamil Nadu, the financial burden on patients undergoing these procedures in public healthcare facilities remains a concern. Hence, this study was done to assess the OOPE and its determinants amongst patients undergoing CT, MRI and PET scan procedures in public healthcare facilities of Tamil Nadu.

Methods

This cross-sectional study analysed OOPE among 2415 patients undergoing advanced radiological procedures in public healthcare facilities across 12 districts in Tamil Nadu. A two-step sampling strategy was employed to select 23 healthcare facilities. Patient-level costs were calculated, including direct medical, direct non-medical, and indirect costs. Determinants of OOPE were assessed using log-linear regression models.

Results

PET scans were the costliest procedure, with median total cost per patient of INR 12,150 (USD 147.14), primarily due to direct medical expenses. Median total costs per patient for CT and MRI scans were INR 1460 (USD 17.68) and INR 3250 (USD 39.36), respectively. Factors significantly associated with higher OOPE included urban residence (e^β = 1.13 for CT; 1.17 for MRI), higher socioeconomic status (e^β = 1.25 for Class I vs. V in CT; 1.45 for Class I vs. V in MRI), lack of insurance utilisation (e^β = 1.75 for CT; 3.73 for MRI), absence of insurance (e^β = 1.89 for CT; 3.85 for MRI), greater travel distance (e^β = 1.51 for CT; 1.56 for MRI), and longer waiting times (e^β = 1.21 for CT).

Conclusions

The study reveals significant financial burdens on patients undergoing advanced radiological procedures, highlighting the need for policy reforms to enhance insurance coverage utilisation, reduce urban-rural disparities, and improve access to affordable care. Addressing these determinants is crucial for reducing OOPE and ensuring equitable access to essential diagnostic services.

背景:先进的放射治疗程序,如CT、MRI和PET扫描,对于准确诊断和治疗计划至关重要,但往往导致患者的大量自费支出(OOPE),特别是在印度等发展中国家。尽管泰米尔纳德邦的卫生政策取得了进步,但在公共医疗机构接受这些手术的患者的经济负担仍然令人关切。因此,本研究旨在评估泰米尔纳德邦公共医疗机构中接受CT、MRI和PET扫描的患者的OOPE及其决定因素。方法:本横断面研究分析了泰米尔纳德邦12个地区公共医疗机构接受先进放射治疗的2415名患者的OOPE。采用两步抽样策略选择了23家医疗机构。计算患者层面的成本,包括直接医疗成本、直接非医疗成本和间接成本。使用对数线性回归模型评估OOPE的决定因素。结果:PET扫描是最昂贵的程序,每位患者的平均总费用为12,150印度卢比(147.14美元),主要是由于直接医疗费用。每位患者CT和MRI扫描的中位总费用分别为1460印度卢比(17.68美元)和3250印度卢比(39.36美元)。与较高的OOPE显著相关的因素包括城市居住(CT的e^β = 1.13;MRI为1.17),较高的社会经济地位(e^β = 1.25);MRI中I类与V类的比值为1.45),缺乏保险利用(CT中的e^β = 1.75;MRI为3.73),无保险(CT = 1.89;3.85 MRI),更大的行程距离(e^β = 1.51 CT;MRI为1.56),等待时间更长(CT为1.21)。结论:该研究揭示了接受先进放射治疗的患者的巨大经济负担,强调了政策改革的必要性,以提高保险覆盖率的利用率,缩小城乡差距,并改善可负担医疗服务的可及性。解决这些决定因素对于减少室外病和确保公平获得基本诊断服务至关重要。
{"title":"Out-of-Pocket Expenditure and its Determinants Amongst the Patients Undergoing Advanced Radiological Procedures in the Public Healthcare Facilities of Tamil Nadu, South India","authors":"Dhanajayan Govindan,&nbsp;Suthanthira Kannan,&nbsp;Deivasigamani Kuberan,&nbsp;Arivarasan Barathi,&nbsp;Venmathi Elangovan,&nbsp;Afrith John Poul,&nbsp;Muneera Parveen,&nbsp;Marie Gilbert Majella,&nbsp;Yuvaraj Krishnamoorthy","doi":"10.1002/hpm.70006","DOIUrl":"10.1002/hpm.70006","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Advanced radiological procedures, such as CT, MRI, and PET scans, are crucial for accurate diagnostics and treatment planning but often result in substantial out-of-pocket expenditures (OOPE) for patients, especially in developing countries like India. Despite progressive health policies in Tamil Nadu, the financial burden on patients undergoing these procedures in public healthcare facilities remains a concern. Hence, this study was done to assess the OOPE and its determinants amongst patients undergoing CT, MRI and PET scan procedures in public healthcare facilities of Tamil Nadu.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This cross-sectional study analysed OOPE among 2415 patients undergoing advanced radiological procedures in public healthcare facilities across 12 districts in Tamil Nadu. A two-step sampling strategy was employed to select 23 healthcare facilities. Patient-level costs were calculated, including direct medical, direct non-medical, and indirect costs. Determinants of OOPE were assessed using log-linear regression models.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>PET scans were the costliest procedure, with median total cost per patient of INR 12,150 (USD 147.14), primarily due to direct medical expenses. Median total costs per patient for CT and MRI scans were INR 1460 (USD 17.68) and INR 3250 (USD 39.36), respectively. Factors significantly associated with higher OOPE included urban residence (e^<i>β</i> = 1.13 for CT; 1.17 for MRI), higher socioeconomic status (e^<i>β</i> = 1.25 for Class I vs. V in CT; 1.45 for Class I vs. V in MRI), lack of insurance utilisation (e^<i>β</i> = 1.75 for CT; 3.73 for MRI), absence of insurance (e^<i>β</i> = 1.89 for CT; 3.85 for MRI), greater travel distance (e^<i>β</i> = 1.51 for CT; 1.56 for MRI), and longer waiting times (e^<i>β</i> = 1.21 for CT).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The study reveals significant financial burdens on patients undergoing advanced radiological procedures, highlighting the need for policy reforms to enhance insurance coverage utilisation, reduce urban-rural disparities, and improve access to affordable care. Addressing these determinants is crucial for reducing OOPE and ensuring equitable access to essential diagnostic services.</p>\u0000 </section>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 6","pages":"1208-1219"},"PeriodicalIF":1.8,"publicationDate":"2025-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers and Strategies for Inclusion of Value-Based Healthcare in Contract Negotiations in the Netherlands: Study Among Hospital and Insurer Executives 在荷兰的合同谈判中纳入基于价值的医疗保健的障碍和策略:医院和保险公司高管之间的研究。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-06-19 DOI: 10.1002/hpm.70003
Diogo L. L. Leao, Dennis van Veghel, Lise A. M. Moers, Wim Groot, Milena Pavlova

Background

This paper analyses why, despite its recognized importance, value-based healthcare (VBHC) has not gained more prominence in negotiations between health insurers and hospitals in the Netherlands.

Methods

Data collected by interviews used a standardized questionnaire with closed- and open-ended questions. Respondents included hospital and insurer executives, and experts on VBHC in the Netherlands.

Results

Hospital and insurer executives addressed issues of cost containment, volume management, and care availability. Despite recognising the potential of VBHC to enhance patient outcomes and experiences, reluctance persists due to uncertainties about cost-savings, its complexity, lack of data, and competing priorities. Hospital executives advocated experiments with VBHC, trust-building, and continuous evaluation, with strategies to standardise measures, enhance information technology (IT) infrastructure, promote data transparency, foster collaboration, and educate stakeholders. Participants also underlined the need for systemic change and governmental action.

Conclusions

Negotiations mostly focus on cost containment and volume management. This reflects a systemic emphasis on immediate financial concerns over long-term value creation. The hesitancy in transitioning to VBHC underscores the need for collaborative strategies and systemic shifts to prioritise patient-centric care. External factors such as fee-for-service payment systems further complicate VBHC adoption, requiring governmental intervention and cultural transformation to align incentives and promote sustainable healthcare practices.

背景:本文分析了为什么,尽管其公认的重要性,价值为基础的医疗保健(VBHC)没有获得更突出的健康保险公司和医院之间的谈判在荷兰。方法:采用标准化问卷,采用封闭式和开放式问题进行访谈。受访者包括医院和保险公司的高管,以及荷兰的VBHC专家。结果:医院和保险公司管理人员解决了成本控制、数量管理和护理可用性等问题。尽管认识到VBHC在改善患者预后和体验方面的潜力,但由于成本节约的不确定性、其复杂性、缺乏数据以及优先事项的竞争,人们仍然不愿意使用VBHC。医院管理人员提倡对VBHC进行实验、建立信任和持续评估,并制定策略来标准化措施、增强信息技术(IT)基础设施、提高数据透明度、促进协作和教育利益相关者。与会者还强调有必要进行系统改革和政府采取行动。结论:谈判主要集中在成本控制和数量管理上。这反映出系统性地强调当前的财务问题,而不是长期价值创造。向VBHC过渡的犹豫不决强调了协作战略和系统转变的必要性,以优先考虑以患者为中心的护理。诸如按服务收费的支付系统等外部因素使VBHC的采用进一步复杂化,需要政府干预和文化转型来协调激励措施并促进可持续的医疗保健实践。
{"title":"Barriers and Strategies for Inclusion of Value-Based Healthcare in Contract Negotiations in the Netherlands: Study Among Hospital and Insurer Executives","authors":"Diogo L. L. Leao,&nbsp;Dennis van Veghel,&nbsp;Lise A. M. Moers,&nbsp;Wim Groot,&nbsp;Milena Pavlova","doi":"10.1002/hpm.70003","DOIUrl":"10.1002/hpm.70003","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>This paper analyses why, despite its recognized importance, value-based healthcare (VBHC) has not gained more prominence in negotiations between health insurers and hospitals in the Netherlands.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data collected by interviews used a standardized questionnaire with closed- and open-ended questions. Respondents included hospital and insurer executives, and experts on VBHC in the Netherlands.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Hospital and insurer executives addressed issues of cost containment, volume management, and care availability. Despite recognising the potential of VBHC to enhance patient outcomes and experiences, reluctance persists due to uncertainties about cost-savings, its complexity, lack of data, and competing priorities. Hospital executives advocated experiments with VBHC, trust-building, and continuous evaluation, with strategies to standardise measures, enhance information technology (IT) infrastructure, promote data transparency, foster collaboration, and educate stakeholders. Participants also underlined the need for systemic change and governmental action.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Negotiations mostly focus on cost containment and volume management. This reflects a systemic emphasis on immediate financial concerns over long-term value creation. The hesitancy in transitioning to VBHC underscores the need for collaborative strategies and systemic shifts to prioritise patient-centric care. External factors such as fee-for-service payment systems further complicate VBHC adoption, requiring governmental intervention and cultural transformation to align incentives and promote sustainable healthcare practices.</p>\u0000 </section>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 6","pages":"1193-1207"},"PeriodicalIF":1.8,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hpm.70003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144334180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence and Corruption: Opportunities and Challenges in the Health Sector 人工智能与腐败:卫生部门的机遇与挑战。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-06-11 DOI: 10.1002/hpm.70002
Paula del Rey-Puech, Dina Balabanova, Martin McKee

Corruption in health systems diverts resources, erodes trust, and reduces service quality. Traditional oversight methods struggle to detect fraudulent patterns, but Artificial Intelligence (AI) offers new possibilities. AI can analyse large datasets to predict corruption risks and detect irregularities in procurement, insurance claims, and counterfeit medicines. Successful applications include AI-powered tools that flag suspicious transactions, expose bid-rigging in procurement, and identify fraudulent medical billing. AI can also complement other analytical tools to help track counterfeit drug supply chains through image recognition and network analysis. However, AI's impact depends on how it is deployed. Government-led AI initiatives may enhance transparency but risk reinforcing power imbalances or enabling authoritarian control. In contrast, civil society-driven efforts can empower citizens to hold authorities accountable but face challenges like limited data access and misinformation risks. Moreover, AI can also facilitate corruption in the health system through biased algorithms, deepfake propaganda, or manipulated AI-driven decision-making in resource allocation. Maximising AI's anti-corruption potential in healthcare requires investments in skilled personnel and data systems. AI should complement human oversight, with transparent auditing mechanisms to mitigate biases. Integrating blockchain and AI technologies may enhance accountability by securing procurement records and preventing data manipulation. While AI presents significant opportunities, its application to anti-corruption remains a political issue as much as a technological one. Careful governance, ethical and legal safeguards, and balanced implementation will determine whether AI combats corruption or exacerbates abuses.

卫生系统中的腐败转移了资源,侵蚀了信任,降低了服务质量。传统的监管方法很难发现欺诈模式,但人工智能(AI)提供了新的可能性。人工智能可以分析大型数据集,以预测腐败风险,并发现采购、保险索赔和假药方面的违规行为。成功的应用包括人工智能工具,这些工具可以标记可疑交易,揭露采购中的操纵投标行为,并识别欺诈性医疗账单。人工智能还可以补充其他分析工具,通过图像识别和网络分析来帮助跟踪假药供应链。然而,人工智能的影响取决于它的部署方式。政府主导的人工智能计划可能会提高透明度,但可能会加剧权力不平衡或实现威权控制。相比之下,民间社会推动的努力可以增强公民对当局问责的能力,但也面临数据获取受限和错误信息风险等挑战。此外,人工智能还可以通过有偏见的算法、深度虚假宣传或操纵人工智能驱动的资源分配决策,促进卫生系统的腐败。最大限度地发挥人工智能在医疗保健领域的反腐败潜力,需要对熟练人员和数据系统进行投资。人工智能应该补充人类的监督,通过透明的审计机制来减轻偏见。整合区块链和人工智能技术可以通过保护采购记录和防止数据操纵来加强问责制。尽管人工智能带来了巨大的机遇,但它在反腐败方面的应用仍然是一个政治问题,同样也是一个技术问题。谨慎的治理、道德和法律保障以及平衡的实施将决定人工智能是打击腐败还是加剧滥用。
{"title":"Artificial Intelligence and Corruption: Opportunities and Challenges in the Health Sector","authors":"Paula del Rey-Puech,&nbsp;Dina Balabanova,&nbsp;Martin McKee","doi":"10.1002/hpm.70002","DOIUrl":"10.1002/hpm.70002","url":null,"abstract":"<p>Corruption in health systems diverts resources, erodes trust, and reduces service quality. Traditional oversight methods struggle to detect fraudulent patterns, but Artificial Intelligence (AI) offers new possibilities. AI can analyse large datasets to predict corruption risks and detect irregularities in procurement, insurance claims, and counterfeit medicines. Successful applications include AI-powered tools that flag suspicious transactions, expose bid-rigging in procurement, and identify fraudulent medical billing. AI can also complement other analytical tools to help track counterfeit drug supply chains through image recognition and network analysis. However, AI's impact depends on how it is deployed. Government-led AI initiatives may enhance transparency but risk reinforcing power imbalances or enabling authoritarian control. In contrast, civil society-driven efforts can empower citizens to hold authorities accountable but face challenges like limited data access and misinformation risks. Moreover, AI can also facilitate corruption in the health system through biased algorithms, deepfake propaganda, or manipulated AI-driven decision-making in resource allocation. Maximising AI's anti-corruption potential in healthcare requires investments in skilled personnel and data systems. AI should complement human oversight, with transparent auditing mechanisms to mitigate biases. Integrating blockchain and AI technologies may enhance accountability by securing procurement records and preventing data manipulation. While AI presents significant opportunities, its application to anti-corruption remains a political issue as much as a technological one. Careful governance, ethical and legal safeguards, and balanced implementation will determine whether AI combats corruption or exacerbates abuses.</p>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 6","pages":"1341-1347"},"PeriodicalIF":1.8,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hpm.70002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Workers in Sub-Saharan Africa: Concurrent Skilled Health Worker Shortages and Under-Employment 撒哈拉以南非洲的卫生工作者:同时出现的熟练卫生工作者短缺和就业不足。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-06-11 DOI: 10.1002/hpm.70001
Pieternella Pieterse

In 2021, the World Health Organization (WHO) introduced the Health Workforce Support and Safeguards List, updating the 2010 WHO Global Code of Practice on the International Recruitment of Health Personnel. The change introduced a new way of defining what constitutes a country with a critical health worker shortage. The new calculations are based on a combined score of countries' health worker density per 1000 population and the Universal Health Coverage (UHC) service coverage index. It has led to an increase in the number of low- and middle-income countries (LMICs) considered at risk from active recruitment by high income countries (HICs). However, the 2021 WHO Safeguard list review failed to explicitly recognise the main causes of low health worker density in countries on the list. Many included countries are unable or unwilling to invest in their health sectors, which restricts the number of staff that can be hired. These countries experience high unemployment among trained and qualified health workers, despite their high need for health workers. Recent dramatic reductions in international aid and development support, means that LMICs that fail to invest in their health workforce, will face ever greater shortfalls in meeting the basic health needs of their populations. For WHO Safeguard-listed countries establishing bilateral health worker migration agreements, better support is needed to create fair deals that allow them to receive compensation from destination countries for the training costs of their emigrating health workers, which can be used to directly hire additional health workers back home.

2021年,世界卫生组织(世卫组织)推出了卫生人力支持和保障清单,更新了2010年世卫组织《全球卫生人员国际招聘行为守则》。这一变化引入了一种新的方式来定义卫生工作者严重短缺的国家。新的计算基于各国每1000人卫生工作者密度和全民健康覆盖服务覆盖指数的综合得分。它导致被认为面临高收入国家积极招聘风险的低收入和中等收入国家(LMICs)数量增加。然而,2021年世卫组织保障措施清单审查未能明确认识到清单上国家卫生工作者密度低的主要原因。许多列入名单的国家不能或不愿对其卫生部门进行投资,这限制了可雇用的工作人员数量。这些国家训练有素和合格的卫生工作者的失业率很高,尽管它们对卫生工作者的需求很大。最近国际援助和发展支持的大幅减少意味着未能投资于其卫生人力的中低收入国家在满足其人口的基本卫生需求方面将面临更大的短缺。对于建立双边卫生工作者移徙协定的世卫组织保障名单国家,需要更好地支持制定公平协议,使它们能够从目的地国获得移徙卫生工作者培训费用的补偿,这些补偿可用于直接雇用更多的卫生工作者回国。
{"title":"Health Workers in Sub-Saharan Africa: Concurrent Skilled Health Worker Shortages and Under-Employment","authors":"Pieternella Pieterse","doi":"10.1002/hpm.70001","DOIUrl":"10.1002/hpm.70001","url":null,"abstract":"<p>In 2021, the World Health Organization (WHO) introduced the Health Workforce Support and Safeguards List, updating the 2010 WHO Global Code of Practice on the International Recruitment of Health Personnel. The change introduced a new way of defining what constitutes a country with a critical health worker shortage. The new calculations are based on a combined score of countries' health worker density per 1000 population and the Universal Health Coverage (UHC) service coverage index. It has led to an increase in the number of low- and middle-income countries (LMICs) considered at risk from active recruitment by high income countries (HICs). However, the 2021 WHO Safeguard list review failed to explicitly recognise the main causes of low health worker density in countries on the list. Many included countries are unable or unwilling to invest in their health sectors, which restricts the number of staff that can be hired. These countries experience high unemployment among trained and qualified health workers, despite their high need for health workers. Recent dramatic reductions in international aid and development support, means that LMICs that fail to invest in their health workforce, will face ever greater shortfalls in meeting the basic health needs of their populations. For WHO Safeguard-listed countries establishing bilateral health worker migration agreements, better support is needed to create fair deals that allow them to receive compensation from destination countries for the training costs of their emigrating health workers, which can be used to directly hire additional health workers back home.</p>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 6","pages":"1335-1340"},"PeriodicalIF":1.8,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hpm.70001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distress Financing for Institutional Delivery in India: A Regional Analysis of Economic Inequality, Coping Mechanisms, and Contributing Factors 印度机构交付的困境融资:经济不平等、应对机制和促成因素的区域分析。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-06-07 DOI: 10.1002/hpm.3950
Puja Pal, Md. Juel Rana

Background

Financial hardship is among the significant challenges in the utilization of maternal healthcare services in India. It is further aggravated by the issue of inequality in the distress financing (DF) for institutional delivery (ID) which pushes the poor into a vicious cycle of poverty. The paper examines the pattern of inequality and regional variation in DF for ID in India. It also determines the factor contributing to the inequality in the DF for ID among a few selected states.

Methods

The paper uses unit-level data from the fifth National Family Health Survey (NFHS-5) round conducted during 2019-21. The concentration curve (CC) and concentration index (CI) capture the inequalities in DF for ID. Also, the decomposition analysis of CI was performed to capture the contribution of key determinants in explaining the inequality in DF for ID.

Results

The study reveals that 16.3% of women in India incurred DF for ID, with the poorest quintile facing the highest burden (21.2%). Significant regional variations exist, with states like Telangana (30%) and Manipur (29.9%) showing the highest DF rates. Borrowing is the primary coping mechanism, particularly among the poorest. The concentration index (CI) analysis indicates that DF dominates among poorer women across states. Decomposition analysis highlights wealth status and education as the major contributors to inequality in DF, with significant regional disparities.

Conclusions

Addressing DF for ID requires strengthening maternity benefit schemes like Janani Suraksha Yojana (JSY) to cover indirect costs and ensure timely disbursements while curbing informal charges. Reducing out-of-pocket expenditure (OOPE) through improving accessibility and quality of public hospitals and regulation of private facility fees is essential. Alongside, expanding health insurance for comprehensive maternity care is essential, particularly in high-inequality states like Telangana, Kerala, and Tamil Nadu. Promoting women's education and economic empowerment, could play a critical role in mitigating long-term disparities in healthcare.

背景:经济困难是印度利用孕产妇保健服务面临的重大挑战之一。制度交付(ID)的困境融资(DF)不平等问题进一步加剧了这一问题,这将穷人推入贫困的恶性循环。本文考察了印度gdp的不平等格局和地区差异。它还决定了在几个选定的州中导致ID DF不平等的因素。方法:本文使用2019-21年第五轮全国家庭健康调查(NFHS-5)的单位数据。浓度曲线(CC)和浓度指数(CI)反映了DF对ID的不平等。此外,对CI进行了分解分析,以捕捉关键决定因素在解释DF对ID的不平等方面的贡献。结果:研究显示,16.3%的印度妇女因ID而接受DF,其中最贫穷的五分之一面临着最高的负担(21.2%)。显著的地区差异存在,像特伦甘纳邦(30%)和曼尼普尔邦(29.9%)这样的邦显示出最高的DF率。借款是主要的应对机制,对最贫穷的人来说尤其如此。浓度指数(CI)分析表明,DF在各州的贫困妇女中占主导地位。分解分析表明,财富状况和教育是造成发展中国家不平等的主要因素,地区差异显著。结论:解决残疾补贴问题需要加强Janani Suraksha Yojana (JSY)等产妇福利计划,以覆盖间接成本并确保及时支付,同时遏制非正式收费。必须通过改善公立医院的可及性和质量以及管制私立医院的收费来减少自付费用。此外,扩大全面产妇保健的医疗保险至关重要,特别是在特伦甘纳邦、喀拉拉邦和泰米尔纳德邦等不平等程度高的邦。促进妇女的教育和经济赋权,可在减轻保健方面的长期差距方面发挥关键作用。
{"title":"Distress Financing for Institutional Delivery in India: A Regional Analysis of Economic Inequality, Coping Mechanisms, and Contributing Factors","authors":"Puja Pal,&nbsp;Md. Juel Rana","doi":"10.1002/hpm.3950","DOIUrl":"10.1002/hpm.3950","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Financial hardship is among the significant challenges in the utilization of maternal healthcare services in India. It is further aggravated by the issue of inequality in the distress financing (DF) for institutional delivery (ID) which pushes the poor into a vicious cycle of poverty. The paper examines the pattern of inequality and regional variation in DF for ID in India. It also determines the factor contributing to the inequality in the DF for ID among a few selected states.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The paper uses unit-level data from the fifth National Family Health Survey (NFHS-5) round conducted during 2019-21. The concentration curve (CC) and concentration index (CI) capture the inequalities in DF for ID. Also, the decomposition analysis of CI was performed to capture the contribution of key determinants in explaining the inequality in DF for ID.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The study reveals that 16.3% of women in India incurred DF for ID, with the poorest quintile facing the highest burden (21.2%). Significant regional variations exist, with states like Telangana (30%) and Manipur (29.9%) showing the highest DF rates. Borrowing is the primary coping mechanism, particularly among the poorest. The concentration index (CI) analysis indicates that DF dominates among poorer women across states. Decomposition analysis highlights wealth status and education as the major contributors to inequality in DF, with significant regional disparities.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Addressing DF for ID requires strengthening maternity benefit schemes like Janani Suraksha Yojana (JSY) to cover indirect costs and ensure timely disbursements while curbing informal charges. Reducing out-of-pocket expenditure (OOPE) through improving accessibility and quality of public hospitals and regulation of private facility fees is essential. Alongside, expanding health insurance for comprehensive maternity care is essential, particularly in high-inequality states like Telangana, Kerala, and Tamil Nadu. Promoting women's education and economic empowerment, could play a critical role in mitigating long-term disparities in healthcare.</p>\u0000 </section>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 5","pages":"1151-1166"},"PeriodicalIF":1.8,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Pandemic Agreement: What's Next? 流行病协议:下一步是什么?
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-05-29 DOI: 10.1002/hpm.70000
Tiago Correia, Marine Buissonnière, Martin McKee

The COVID-19 pandemic exposed critical weaknesses in global health governance, prompting the development of the WHO Pandemic Agreement, formally adopted by the World Health Assembly in May 2025. This landmark Agreement seeks to address the shortcomings of the 2005 International Health Regulations by establishing legally binding commitments to enhance pandemic preparedness, equity, and international solidarity. However, the negotiation process revealed deep geopolitical divisions, raising concerns about the Agreement's legitimacy and enforceability. Key provisions include improved surveillance, data sharing, protection for healthcare workers, and equitable access to medical countermeasures. Nevertheless, its effectiveness may be compromised by vague language, unresolved issues, and the absence or abstention of influential states. Implementation is further challenged by political fragmentation, sovereignty concerns, and disparities in national capacities. The Agreement's success will depend on sustained political will, robust accountability mechanisms, and meaningful national adoption. Ongoing debates over the definition of ‘pandemic’ and the WHO's limited enforcement powers underscore the tension between multilateral cooperation and national sovereignty. While the Agreement represents a significant step forward, it is not a panacea. Its promise lies in its potential to catalyse coordinated global action, but only if supported by genuine commitment and adaptive governance. As the world faces future health threats, the Pandemic Agreement must evolve into a practical tool for resilience, equity, and collective security.

2019冠状病毒病大流行暴露了全球卫生治理的严重弱点,促使世卫组织制定了《大流行协定》,并于2025年5月由世界卫生大会正式通过。这一具有里程碑意义的协定旨在通过确立具有法律约束力的承诺,加强大流行防范、公平和国际团结,解决2005年《国际卫生条例》的不足。然而,谈判过程暴露出深刻的地缘政治分歧,引发了对《协定》合法性和可执行性的担忧。主要条款包括改进监测、数据共享、保护卫生保健工作者以及公平获得医疗对策。然而,其效力可能会受到含糊的语言、未解决的问题以及有影响力的国家缺席或弃权的影响。政治分裂、主权问题和国家能力的差异进一步挑战了执行工作。该协定的成功将取决于持续的政治意愿、强有力的问责机制和有意义的国家采纳。正在进行的关于“大流行”的定义和世卫组织有限的执法权力的辩论强调了多边合作与国家主权之间的紧张关系。虽然《协定》是向前迈出的重要一步,但它不是万灵药。它的希望在于它有潜力促进协调一致的全球行动,但前提是得到真正承诺和适应性治理的支持。随着世界面临未来的卫生威胁,《大流行协定》必须发展成为增强韧性、公平和集体安全的实用工具。
{"title":"The Pandemic Agreement: What's Next?","authors":"Tiago Correia,&nbsp;Marine Buissonnière,&nbsp;Martin McKee","doi":"10.1002/hpm.70000","DOIUrl":"10.1002/hpm.70000","url":null,"abstract":"<p>The COVID-19 pandemic exposed critical weaknesses in global health governance, prompting the development of the WHO Pandemic Agreement, formally adopted by the World Health Assembly in May 2025. This landmark Agreement seeks to address the shortcomings of the 2005 International Health Regulations by establishing legally binding commitments to enhance pandemic preparedness, equity, and international solidarity. However, the negotiation process revealed deep geopolitical divisions, raising concerns about the Agreement's legitimacy and enforceability. Key provisions include improved surveillance, data sharing, protection for healthcare workers, and equitable access to medical countermeasures. Nevertheless, its effectiveness may be compromised by vague language, unresolved issues, and the absence or abstention of influential states. Implementation is further challenged by political fragmentation, sovereignty concerns, and disparities in national capacities. The Agreement's success will depend on sustained political will, robust accountability mechanisms, and meaningful national adoption. Ongoing debates over the definition of ‘pandemic’ and the WHO's limited enforcement powers underscore the tension between multilateral cooperation and national sovereignty. While the Agreement represents a significant step forward, it is not a panacea. Its promise lies in its potential to catalyse coordinated global action, but only if supported by genuine commitment and adaptive governance. As the world faces future health threats, the Pandemic Agreement must evolve into a practical tool for resilience, equity, and collective security.</p>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"40 5","pages":"1029-1032"},"PeriodicalIF":1.8,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hpm.70000","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144181702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Health Planning and Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1